Enpatoran Human Mass Balance and Absolute Bioavailability Study
Clinical trial NCT05110027 · COMPLETED
Trial details
- NCT number
- NCT05110027
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-05
- Primary completion
- 2021-12-24
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.